DOR BioPharma, Inc. (AMEX:DOR) (“DOR”, or the “Company”), today announced that Gregory J. Davenport, Ph.D., President of DOR’s BioDefense Division, will participate as a panelist during a BioDefense Briefing scheduled for Thursday, September 23, 8:00 - 11:00 A.M., in the Ballroom at the National Press Club in Washington.
